Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wilson

Showing results (181-190 of 546) with videos related to

Pageof 55
Sort By:
International Journal of Cardiology|July 18, 2017
Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery diseaseIssada Trakarnwijitr, Bobby Li, Heath Adams, et al.
BMJ Supportive & Palliative Care|January 9, 2021
Therapeutic thoracentesis symptoms and activity: a qualitative studyChloe Twose, Rebecca Ferris, Andrew Wilson, et al.
Journal of Primary Health Care|September 29, 2020
"She'll be right, mate!": do Australians take their health for granted?Paul Harris, Asiyeh Salehi, Elizabeth Kendall, et al.
Clinical Rehabilitation|September 10, 2020
Aquatic high intensity interval training to improve aerobic capacity is feasible in adolescents with cerebral palsy: pilot randomised controlled trialJulie Depiazzi, Nadine Smith, Noula Gibson, et al.
European Journal of Pharmacology|May 17, 2005
Estradiol protects against alteration of protein kinase C(epsilon) in a binge model of ethanol dependence and withdrawalMarianna Eunsun Jung, Stephanie Jacobs, Mridula Rewal, et al.
Orphanet Journal of Rare Diseases|March 22, 2022
A brief history of MECP2 duplication syndrome: 20-years of clinical understandingDaniel Ta, Jenny Downs, Gareth Baynam, et al.
Alcoholism, Clinical and Experimental Research|November 5, 2005
Role of parvalbumin in estrogen protection from ethanol withdrawal syndromeMridula Rewal, Yi Wen, Andrew Wilson, et al.
British Journal of Haematology|August 12, 2009
Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapyTamara Intermesoli, Jonathan Shamash, Ama Rohatiner, et al.
Transplantation Reviews (Orlando, Fla.)|March 23, 2023
Factors associated with health inequities in access to kidney transplantation in the USA: A scoping reviewZachary Ernst, Andrew Wilson, Andriana Peña, et al.
Orphanet Journal of Rare Diseases|January 15, 2026
Functional skills in MECP2 duplication syndrome: developmental dynamics and regressionDaniel Ta, Jenny Downs, Gareth Baynam, et al.
Pageof 55

Showing results (181-190 of 546) with videos related to

Sort By:
Pageof 55
International Journal of Cardiology|July 18, 2017
Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery diseaseIssada Trakarnwijitr, Bobby Li, Heath Adams, et al.
BMJ Supportive & Palliative Care|January 9, 2021
Therapeutic thoracentesis symptoms and activity: a qualitative studyChloe Twose, Rebecca Ferris, Andrew Wilson, et al.
Journal of Primary Health Care|September 29, 2020
"She'll be right, mate!": do Australians take their health for granted?Paul Harris, Asiyeh Salehi, Elizabeth Kendall, et al.
Clinical Rehabilitation|September 10, 2020
Aquatic high intensity interval training to improve aerobic capacity is feasible in adolescents with cerebral palsy: pilot randomised controlled trialJulie Depiazzi, Nadine Smith, Noula Gibson, et al.
European Journal of Pharmacology|May 17, 2005
Estradiol protects against alteration of protein kinase C(epsilon) in a binge model of ethanol dependence and withdrawalMarianna Eunsun Jung, Stephanie Jacobs, Mridula Rewal, et al.
Orphanet Journal of Rare Diseases|March 22, 2022
A brief history of MECP2 duplication syndrome: 20-years of clinical understandingDaniel Ta, Jenny Downs, Gareth Baynam, et al.
Alcoholism, Clinical and Experimental Research|November 5, 2005
Role of parvalbumin in estrogen protection from ethanol withdrawal syndromeMridula Rewal, Yi Wen, Andrew Wilson, et al.
British Journal of Haematology|August 12, 2009
Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapyTamara Intermesoli, Jonathan Shamash, Ama Rohatiner, et al.
Transplantation Reviews (Orlando, Fla.)|March 23, 2023
Factors associated with health inequities in access to kidney transplantation in the USA: A scoping reviewZachary Ernst, Andrew Wilson, Andriana Peña, et al.
Orphanet Journal of Rare Diseases|January 15, 2026
Functional skills in MECP2 duplication syndrome: developmental dynamics and regressionDaniel Ta, Jenny Downs, Gareth Baynam, et al.
Pageof 55